Saturday, April 11, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

Journalists Must Address Lax Oversight on Research Data

Report what doesn't add up

Denise-Marie Ordway by Denise-Marie Ordway
May 15, 2024
in Innovations & Investing
0
Journalists Must Address Lax Oversight on Research Data

The Climate Reality Project

Uri Simonsohn is an outspoken advocate for open science — adding transparency to the research process and helping researchers share what they’ve learned in greater detail with a broad audience.

Many people know Simonsohn for his data analyses on Data Colada, a blog about social science research he writes with two other behavioral scientists, Leif Nelson and Joseph Simmons. The three scholars, who co-direct the Wharton Credibility Lab at the University of Pennsylvania, occasionally use the blog to spotlight evidence of suspected fraud they’ve found in academic papers.

In his role at the Credibility Lab and as a professor at Esade Business School in Barcelona, Simonsohn travels to speak on issues around scientific integrity and data science. During his recent visit to Harvard University, The Journalist’s Resource asked for his thoughts on how journalists can improve their coverage of academic fraud and misconduct.

Here are three big takeaways from our conversation.

1. Before covering academic studies, ask researchers about preregistration.

Preregistration is “the practice of documenting your research plan at the beginning of your study and storing that plan in a read-only public repository such as OSF Registries or the National Library of Medicine’s Clinical Trials Registry,” according to the nonprofit Center for Open Science. Simonsohn says preregistration helps prevent research fraud. When researchers create a permanent record outlining how they intend to conduct a study before they start, they are discouraged from changing parts of their study — for instance, their hypothesis or study sample — to get a certain result.

Simonsohn adds that preregistration also reduces what’s known as “p-hacking,” or manipulating an analysis of data to make it seem as though patterns in the data are statistically significant when they are not. Examples of p-hacking: Adding more data or control variables to change the result or deciding after the analysis is complete to exclude some data. (For more on statistical significance, read our tip sheet on the topic.)

Preregistration is particularly important when researchers will be collecting their own data, Simonsohn points out. It’s easier to alter or fabricate data when you collect it yourself, especially if there’s no expectation to share the raw data.

While preregistration is the norm in clinical trials, it’s less common in other research fields. About half of psychology research is preregistered as is about a quarter of marketing research, Simonsohn says. A substantial proportion of economic research is not, however, because it often relies on data collected by other researchers or nonprofit organizations and government agencies such as the U.S. Census Bureau.

Simonsohn urges journalists to ask researchers whether they preregistered their studies before reporting on them. He likened reporting on research that isn’t preregistered to driving a car that hasn’t been inspected. The car might be perfectly safe, but you can’t be sure because no one has had a chance to look under the hood.

“If the person says ‘no,’ [the journalist] could ask, ‘Oh, how come?’” he says. “And if they don’t provide a compelling reason, the journalist could say ‘You know, I’m not going to cover work that hasn’t been preregistered, without a good rationale.’”

Research registries themselves can be a helpful resource for journalists. The Center for Open Science lets the public search for and read the thousands of preregistered research plans on its Open Science Framework platform. Researchers who preregister their work at AsPredicted, a platform Simonsohn helped create for the Wharton Credibility Lab, can choose whether and when to make their preregistered research plan public.

2. Report on the lack of oversight of research data collection.

Journalists and the public probably don’t realize how little oversight there is when it comes to collecting and analyzing data for research, Simonsohn says. That includes research funded by the federal government, which gives colleges, universities and other organizations billions of dollars a year to study public health, climate change, new technology and other topics.

Simonsohn says there’s no system in place to ensure the integrity of research data or its analysis. Although federal law requires research involving human subjects to be reviewed by an Institutional Review Board, the primary goal of these independent committees is protecting the welfare and rights of study participants.

Academic papers are reviewed by a small group of experts before a scholarly journal will publish them. But the peer-review process isn’t designed to catch research fraud. Reviewers typically do not check the authors’ work to see if they followed the procedures they say they followed to reach their conclusions.

Simonsohn says journalists should investigate the issue and report on it.

“The lack of protection against fraud is a story that deserves to be written,” he says. “When I teach students, they’re shocked. They’re shocked that when you submit a paper to a journal, [the journal is] basically trusting you without any safeguards. You’re not even asked to assert in the affirmative that you haven’t done anything wrong.”

Journalists should also examine ways to prevent fraud, he adds. He thinks researchers should be required to submit “data receipts” to organizations that provide grant funding to show who has had access to, changed or analyzed a study’s raw data and when. This record keeping would be similar to the chain of custody process that law enforcement agencies follow to maintain the legal integrity of the physical evidence they collect.

“That is, by far, the easiest way to stop most of it,” Simonsohn says.

3. Learn about open science practices and the scientists who expose problematic research.

Nearly 200 countries have agreed to follow the common standards for open science that UNESCO, the United Nations’ scientific, educational and cultural organization, created in 2021. In December, UNESCO released a status report of initiatives launched in different parts of the globe to help researchers work together in the open and share what they’ve learned in detail with other researchers and the public. The report notes, for example, that a rising number of countries and research organizations have developed open data policies.

As of January 2024, more than 1,100 open science policies were adopted by research organizations and research funders worldwide, according to the Registry of Open Access Repositories Mandatory Archiving Policies, which tracks policies requiring researchers to make their “research output” public.

In the U.S., the universities and university departments that have adopted these policies include Johns Hopkins University, University of Central Florida, Stanford University’s School of Education and Columbia University’s School of Social Work. Such policies also have been adopted at Harvard Kennedy School and one of its research centers, the Shorenstein Center on Media, Politics and Public Policy, which is where The Journalist’s Resource is housed.

Simonsohn recommends journalists learn about open science practices and familiarize themselves with research watchdogs such as Nick Brown, known for helping expose problems in published studies by prominent nutrition scientist Brian Wansink.

Retraction Watch, a website that tracks research retractions, maintains a list of more than two dozen scientific sleuths. Elisabeth Bik, a microbiologist and science integrity consultant who has been called “the public face of image sleuthing,” was a guest speaker in The Journalist’s Resource’s recent webinar on covering research fraud and errors.

Here are some of the open science organizations that journalists covering these issues will want to know about:

  • The Virginia-based Center for Open Science.
  • The Berkeley Initiative for Transparency in the Social Sciences.
  • Yale University Open Data Access (YODA) Project, an online platform for sharing clinical trial research data.
  • VEDA (Visualization, Exploration, and Data Analysis), NASA’s open-source platform that allows researchers to collaborate on Earth science studies.
  • MedRxiv (pronounced “med-archive”) is an online platform owned and operated by Cold Spring Harbor Laboratory. Researchers can use it to share preprint research — academic papers that present preliminary findings and have not been peer reviewed — on medical, clinical and health science topics.

This article first appeared on The Journalist’s Resource and is republished here under a Creative Commons license.

Source: The Journalist’s Resource
ShareTweet
Denise-Marie Ordway

Denise-Marie Ordway

Denise-Marie Ordway has received a multitude of national, regional and state-level journalism awards and was named as a Pulitzer Prize finalist in 2013 for an investigative series she led that focused on hazing and other problems at Florida A&M University.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Most employers are unknowingly steering their health plans toward higher costs and reduced control — until they understand how fiduciary missteps and anti-competitive contracts bleed their budgets dry. Katie Talento, a recognized health policy leader, reveals how shifting the network paradigm can save millions by emphasizing independent providers, direct contracting, and innovative tiering models.

Grounded in real-world case studies like Harris Rosen’s community-driven initiative, this episode dives deep into practical strategies to realign incentives—focusing on primary care, specialty care, and transparent vendor relationships. You'll discover how traditional carrier networks are often Trojan horses, locking employers into costly, opaque arrangements that undermine fiduciary duties. Katie breaks down simple yet powerful reforms: owning your data, eliminating conflicts of interest, and outlawing anti-competitive contract clauses.

We explore how a post-network framework—where patients are free to choose providers without restrictive network barriers—can massively reduce costs and improve health outcomes. You'll learn why independent, locally owned providers are vital to rebuilding trust, reducing unnecessary procedures, and reinvesting savings into the community. This conversation offers clarity on the unseen legal landmines employers face and actionable ways to craft health plans built on transparency, independence, and aligned incentives.

Perfect for HR pros, benefits advisors, physicians, and employer leaders committed to transforming healthcare from the ground up. If you’re tired of broken healthcare models draining your budget and frustrating your staff, this episode will empower you to take control by understanding and reshaping the very foundations of employer-sponsored health. Discover the blueprint for smarter, fairer, and more sustainable benefits.

Visit katytalento.com or allbetter.health to connect directly and explore how these innovations can work for your organization. Your path toward a healthier, more cost-effective future starts here.

Chapters

00:00 Introduction to Employer-Sponsored Health Plans
02:50 Understanding ERISA and Fiduciary Responsibilities
06:08 The Misalignment of Clinical and Financial Interests
08:54 Enforcement and Legal Implications for Employers
11:49 Redefining Networks: The Post-Network Framework
25:34 Navigating Healthcare Contracts and Cash Payments
27:31 Understanding Employer Health Plan Structures
28:04 The Role of Benefits Advisors in Health Plans
30:45 Governance and Data Ownership in Health Plans
37:05 Case Study: The Rosen Hotels' Health Model
41:33 Incentivizing Healthy Choices in Healthcare
47:22 Empowering Primary Care and Independent Providers
The Hidden Costs Employers Don’t See in Traditional Health Plans
YouTube Video xhks7YbmBoY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

by Daily Remedy
March 30, 2026
0

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Make the Patient Encounter a Conversation

    Make the Patient Encounter a Conversation

    1 shares
    Share 0 Tweet 0
  • 7 Shocking Reasons Why You’re Your Best Advocate

    0 shares
    Share 0 Tweet 0
  • Mechanism vs Evidence

    0 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • The Quiet Geography of H5N1

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy